The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy
Open accessAbstract
The evidence‐ and consensus‐based guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline and Consensus Statement Development Manual. Four consensus conferences were held between December 2020 and July 2021. Twenty‐nine experts (including clinicians and patient representatives) from 12 European countries participated. This first part of the guideline includes general information on its scope and purpose, the health questions covered, target users and a methods section. It also provides guidance on which patients should be treated with systemic therapies, as well as recommendations and detailed information on each systemic drug. The systemic treatment options discussed in the guideline comprise conventional immunosuppressive drugs (azathioprine, ciclosporin, glucocorticosteroids, methotrexate and mycophenolate mofetil), biologics (dupilumab, lebrikizumab, nemolizumab, omalizumab and tralokinumab) and janus kinase inhibitors (abrocitinib, baricitinib and upadacitinib). Part two of the guideline will address avoidance of provocation factors, dietary interventions, immunotherapy, complementary medicine, educational interventions, occupational and psychodermatological aspects, patient perspective and considerations for paediatric, adolescent, pregnant and breastfeeding patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Simpson, E. L., Bieber, T., Guttman-Yassky, E., Beck, L. A., Blauvelt, A., Cork, M. J., Silverberg, J. I., Deleuran, M., Kataoka, Y., Lacour, J.-P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1610020 · Cited by 2,110
Self-citationDupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
Beck, L. A., Thaçi, D., Hamilton, J. D., Graham, N. M., Bieber, T., Rocklin, R., Ming, J. E., Ren, H., Kao, R., Simpson, E., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314768 · Cited by 1,421
Self-citationBlauvelt, A., de Bruin-Weller, M., Gooderham, M., Cather, J. C., Weisman, J., Pariser, D., Simpson, E. L., Papp, K. A., Hong, H. C.-H., Rubel, D., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31191-1 · Cited by 1,261
Self-citationSensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic Itch
Oetjen, L. K., Mack, M. R., Feng, J., Whelan, T. M., Niu, H., Guo, C. J., Chen, S., Trier, A. M., Xu, A. Z., Tripathi, S. V., et al. (2017) · Cell · doi:10.1016/j.cell.2017.08.006 · Cited by 1,092
A meta-analysis of randomized controlled trials: Efficacy of selenium treatment for sepsis
Li, S., Tang, T., Guo, P., Zou, Q., Ao, X., Hu, L., & Tan, L. (2019) · Medicine · doi:10.1097/md.0000000000014733 · Cited by 802
The clinical pharmacology of 6-mercaptopurine
Lennard, L. (1992) · European Journal of Clinical Pharmacology · doi:10.1007/bf02220605 · Cited by 647
Wollenberg, A., Blauvelt, A., Guttman‐Yassky, E., Worm, M., Lynde, C., Lacour, J. ‐., Spelman, L., Katoh, N., Saeki, H., Poulin, Y., et al. (2021) · British Journal of Dermatology · doi:10.1111/bjd.19574 · Cited by 638
Self-citationAnti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis
Ruzicka, T., Hanifin, J. M., Furue, M., Pulka, G., Mlynarczyk, I., Wollenberg, A., Galus, R., Etoh, T., Mihara, R., Yoshida, H., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1606490 · Cited by 592
Self-citationGuttman-Yassky, E., Teixeira, H. D., Simpson, E. L., Papp, K. A., Pangan, A. L., Blauvelt, A., Thaçi, D., Chu, C.-Y., Hong, H. C.-H., Katoh, N., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00588-2 · Cited by 583
Saag, K. G., Koehnke, R., Caldwell, J. R., Brasington, R., Burmeister, L. F., Zimmerman, B., Kohler, J. A., & Furst, D. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90131-7 · Cited by 540
Simpson, E. L., Sinclair, R., Forman, S., Wollenberg, A., Aschoff, R., Cork, M., Bieber, T., Thyssen, J. P., Yosipovitch, G., Flohr, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30732-7 · Cited by 522
Self-citationBlauvelt, A., Teixeira, H. D., Simpson, E. L., Costanzo, A., De Bruin-Weller, M., Barbarot, S., Prajapati, V. H., Lio, P., Hu, X., Wu, T., et al. (2021) · JAMA Dermatology · doi:10.1001/jamadermatol.2021.3023 · Cited by 516
Self-citationWollenberg, A., Christen‐Zäch, S., Taieb, A., Paul, C., Thyssen, J. P., de Bruin‐Weller, M., Vestergaard, C., Seneschal, J., Werfel, T., Cork, M. J., et al. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16892 · Cited by 493
Self-citationBieber, T., de la Salle, H., Wollenberg, A., Hakimi, J., Chizzonite, R., Ring, J., Hanau, D., & de la Salle, C. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.5.1285 · Cited by 481
Self-citationMechanisms of action of mycophenolate mofetil
Allison, A. (2005) · Lupus · doi:10.1177/096120330501400102 · Cited by 480
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis
Bieber, T., Simpson, E. L., Silverberg, J. I., Thaçi, D., Paul, C., Pink, A. E., Kataoka, Y., Chu, C.-Y., DiBonaventura, M., Rojo, R., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2019380 · Cited by 476
Self-citationConjunctivitis in dupilumab clinical trials
Akinlade, B., Guttman‐Yassky, E., Bruin‐Weller, M., Simpson, E. L., Blauvelt, A., Cork, M. J., Prens, E., Asbell, P., Akpek, E., Corren, J., et al. (2019) · British Journal of Dermatology · doi:10.1111/bjd.17869 · Cited by 442
Self-citationFleischmann, R., Schiff, M., van der Heijde, D., Ramos‐Remus, C., Spindler, A., Stanislav, M., Zerbini, C. A. F., Gurbuz, S., Dickson, C., de Bono, S., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.39953 · Cited by 427
Ruzicka, T., Lynde, C. W., Jemec, G. B. E., Diepgen, T., Berth-Jones, J., Coenraads, P. J., Kaszuba, A., Bissonnette, R., Varjonen, E., Holló, P., et al. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08487.x · Cited by 413
Reich, K., Teixeira, H. D., de Bruin-Weller, M., Bieber, T., Soong, W., Kabashima, K., Werfel, T., Zeng, J., Huang, X., Hu, X., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00589-4 · Cited by 402
Self-citationGuttman-Yassky, E., Thaçi, D., Pangan, A. L., Hong, H. C.-H., Papp, K. A., Reich, K., Beck, L. A., Mohamed, M.-E. F., Othman, A. A., Anderson, J. K., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.11.025 · Cited by 369
Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus
Kabashima, K., Matsumura, T., Komazaki, H., & Kawashima, M. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1917006 · Cited by 361
Guttman-Yassky, E., Blauvelt, A., Eichenfield, L. F., Paller, A. S., Armstrong, A. W., Drew, J., Gopalan, R., & Simpson, E. L. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2020.0079 · Cited by 341
Simpson, E. L., Flohr, C., Eichenfield, L. F., Bieber, T., Sofen, H., Taïeb, A., Owen, R., Putnam, W., Castro, M., DeBusk, K., et al. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.01.017 · Cited by 331
Self-citationSilverberg, J. I., Toth, D., Bieber, T., Alexis, A. F., Elewski, B. E., Pink, A. E., Hijnen, D., Jensen, T. N., Bang, B., Olsen, C. K., et al. (2021) · British Journal of Dermatology · doi:10.1111/bjd.19573 · Cited by 326
Self-citationRoekevisch, E., Spuls, P. I., Kuester, D., Limpens, J., & Schmitt, J. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.07.049 · Cited by 322
Schmitt, J., Spuls, P. I., Thomas, K. S., Simpson, E., Furue, M., Deckert, S., Dohil, M., Apfelbacher, C., Singh, J. A., Chalmers, J., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.07.043 · Cited by 319
Emerging Topical and Systemic JAK Inhibitors in Dermatology
Solimani, F., Meier, K., & Ghoreschi, K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02847 · Cited by 308
Meggitt, S. J., Gray, J. C., & Reynolds, N. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68340-2 · Cited by 285
Reich, K., Kabashima, K., Peris, K., Silverberg, J. I., Eichenfield, L. F., Bieber, T., Kaszuba, A., Kolodsick, J., Yang, F. E., Gamalo, M., et al. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2020.3260 · Cited by 285
Self-citationSilverberg, J. I., Pinter, A., Pulka, G., Poulin, Y., Bouaziz, J.-D., Wollenberg, A., Murrell, D. F., Alexis, A., Lindsey, L., Ahmad, F., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.08.013 · Cited by 271 · cited 3×
“58 The authors conclude that longer and larger trials are necessary to determine whether nemolizumab has a durable effect and is safe for AE patients.”
BackgroundSelf-citationCyclosporin in the treatment of patients with atopic eczema – a systematic review and meta‐analysis
Schmitt, J., Schmitt, N., & Meurer, M. (2007) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2006.02023.x · Cited by 265
A randomized trial of methotrexate versus azathioprine for severe atopic eczema
Schram, M. E., Roekevisch, E., Leeflang, M. M. G., Bos, J. D., Schmitt, J., & Spuls, P. I. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.03.024 · Cited by 260
Amano, W., Nakajima, S., Kunugi, H., Numata, Y., Kitoh, A., Egawa, G., Dainichi, T., Honda, T., Otsuka, A., Kimoto, Y., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.03.051 · Cited by 259
Safety and tolerability of omalizumab
Corren, J., Casale, T. B., Lanier, B., Buhl, R., Holgate, S., & Jimenez, P. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03214.x · Cited by 252
Popovic, B., Breed, J., Rees, D. G., Gardener, M. J., Vinall, L. M. K., Kemp, B., Spooner, J., Keen, J., Minter, R., Uddin, F., et al. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.12.005 · Cited by 198
Cyclosporine in severe childhood atopic dermatitis: A multicenter study
Berth-Jones, J., Finlay, A. Y., Zaki, I., Tan, B., Goodyear, H., Lewis-Jones, S., Cork, M. J., Bleehen, S. S., Salek, M. S., Allen, B. R., et al. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90281-9 · Cited by 195
Ortiz, Z., Shea, B., Suarez-Almazor, M. E., Moher, D., Wells, G. A., & Tugwell, P. (1998) · PubMed · Cited by 182
Wollenberg, A., Ariens, L., Thurau, S., van Luijk, C., Seegräber, M., & de Bruin-Weller, M. (2018) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2018.01.034 · Cited by 180
Self-citationEichenfield, L. F., Flohr, C., Sidbury, R., Siegfried, E., Szalai, Z., Galus, R., Yao, Z., Takahashi, H., Barbarot, S., Feeney, C., et al. (2021) · JAMA Dermatology · doi:10.1001/jamadermatol.2021.2830 · Cited by 169
Self-citationAn open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema
Weatherhead, S. C., Wahie, S., Reynolds, N. J., & Meggitt, S. J. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07686.x · Cited by 161
El-Khalawany, M. A., Hassan, H., Shaaban, D., Ghonaim, N., & Eassa, B. (2013) · European Journal of Pediatrics · doi:10.1007/s00431-012-1893-3 · Cited by 159
Drucker, A. M., Ellis, A. G., Bohdanowicz, M., Mashayekhi, S., Yiu, Z. Z. N., Rochwerg, B., Di Giorgio, S., Arents, B. W. M., Burton, T., Spuls, P. I., et al. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2020.0796 · Cited by 159
Self-citationBlauvelt, A., Silverberg, J. I., Lynde, C. W., Bieber, T., Eisman, S., Zdybski, J., Gubelin, W., Simpson, E. L., Valenzuela, F., Criado, P. R., et al. (2022) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2021.05.075 · Cited by 159
Self-citationLow-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels
Belloni, B., Ziai, M., Lim, A., Lemercier, B., Sbornik, M., Weidinger, S., Andres, C., Schnopp, C., Ring, J., Hein, R., et al. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.08.060 · Cited by 157
Self-citationBieber, T., Thyssen, J. P., Reich, K., Simpson, E. L., Katoh, N., Torrelo, A., De Bruin‐Weller, M., Thaci, D., Bissonnette, R., Gooderham, M., et al. (2021) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16948 · Cited by 152
Self-citationWollenberg, A., Beck, L. A., Blauvelt, A., Simpson, E. L., Chen, Z., Chen, Q., Shumel, B. S., Khokhar, F. A., Hultsch, T., Rizova, E., et al. (2019) · British Journal of Dermatology · doi:10.1111/bjd.18434 · Cited by 152
Self-citationSimpson, E. L., Silverberg, J. I., Nosbaum, A., Winthrop, K. L., Guttman‐Yassky, E., Hoffmeister, K. M., Egeberg, A., Valdez, H., Zhang, M., Farooqui, S. A., et al. (2021) · American Journal of Clinical Dermatology · doi:10.1007/s40257-021-00618-3 · Cited by 152
Targeting immunoglobulin E in atopic dermatitis: A review of the existing evidence
Wollenberg, A., Thomsen, S. F., Lacour, J. ‐., Jaumont, X., & Lazarewicz, S. (2021) · World Allergy Organization Journal · doi:10.1016/j.waojou.2021.100519 · Cited by 148
Self-citationMethotrexate in rheumatoid arthritis: a quarter century of development.
Weinblatt, M. E. (2013) · PubMed · Cited by 142
Vestergaard, C., Wollenberg, A., Barbarot, S., Christen‐Zaech, S., Deleuran, M. S., Spuls, P. I., Flohr, C., Trzeciak, M., von Kobyletzki, L., Sénéschal, J., et al. (2019) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.15709 · Cited by 140
Self-citationBeck, L. A., Thaçi, D., Deleuran, M. S., Blauvelt, A., Bissonnette, R., de Bruin-Weller, M. S., Hide, M., Sher, L., Hussain, I., Chen, Z., et al. (2020) · American Journal of Clinical Dermatology · doi:10.1007/s40257-020-00527-x · Cited by 138
Self-citationEfficacy of omalizumab in patients with atopic dermatitis: A systematic review and meta-analysis
Wang, H.-H., Li, Y., & Huang, Y. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.05.038 · Cited by 134
Meggitt, S. J., Anstey, A. V., Mustapa, M. F. M., Reynolds, N. J., Wakelin, S. H., Tidman, M. J., Fuller, L. C., McLelland, J., Lear, J. T., Hughes, J. R., et al. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10575.x · Cited by 133
Upadacitinib plus topical corticosteroids in atopic dermatitis: Week 52 AD Up study results
Silverberg, J. I., de Bruin-Weller, M. S., Bieber, T. R. M., Soong, W., Kabashima, K., Costanzo, A., Rosmarin, D. M., Lynde, C. W., Liu, J., Gamelli, A., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.07.036 · Cited by 132
Self-citationChan, S., Cornelius, V., Cro, S., Harper, J. I., & Lack, G. (2020) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2019.4476 · Cited by 130
Wollenberg, A., Flohr, C., Simon, D., Cork, M. J., Thyssen, J. P., Bieber, T. R. M., de Bruin-Weller, M. S., Weidinger, S., Deleuran, M. S., Taïeb, A., et al. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16411 · Cited by 113
Self-citationCruz, A. A., Lima, F., Sarinho, E., Ayre, G., Martin, C., Fox, H., & Cooper, P. J. (2007) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2007.02650.x · Cited by 111
Silverberg, J. I., Simpson, E. L., Wollenberg, A., Bissonnette, R., Kabashima, K., DeLozier, A. M., Sun, L., Cardillo, T. E., Nunes, F. P., & Reich, K. (2021) · JAMA Dermatology · doi:10.1001/jamadermatol.2021.1273 · Cited by 106
Self-citationLow‐dose methotrexate treatment for moderate‐to‐severe atopic dermatitis in adults
Lyakhovitsky, A., Barzilai, A., Heyman, R., Baum, S., Amichai, B., Solomon, M., Shpiro, D., & Trau, H. (2009) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2009.03351.x · Cited by 101
Systemic methotrexate therapy for psoriasis: past, present and future
Dogra, S., & Mahajan, R. (2013) · Clinical and Experimental Dermatology · doi:10.1111/ced.12062 · Cited by 98
Goujon, C., Viguier, M. A., Staumont-Sallé, D., Bernier, C., Guillet, G., Lahfa, M., le Bouëdec, M.-C. F., Cambazard, F., Bottigioli, D., Grande, S., et al. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.07.007 · Cited by 95
Glucocorticoid withdrawal schemes in chronic medical disorders
Richter, B., Neises, G., & Clar, C. (2002) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(02)00008-7 · Cited by 90
Azathioprine for atopic dermatitis
Meggitt, S. J., & Reynolds, N. J. (2001) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2001.00837.x · Cited by 89
Alqarni, A. M., & Zeidler, M. P. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190803 · Cited by 89
Methotrexate for the treatment of adult atopic dermatitis.
Goujon, C., Bérard, F., Dahel, K., Guillot, I., Hennino, A., Nosbaum, A., Saad, N., & Nicolas, J. (2006) · PubMed · Cited by 83
Silverberg, J. I., Pinter, A., Alavi, A., Lynde, C. W., Bouaziz, J., Wollenberg, A., Murrell, D. F., Alpizar, S., Laquer, V. T., Chaouche‐Teyara, K., et al. (2021) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.17218 · Cited by 60
Self-citationTreatment of atopic eczema with oral alitretinoin
Grahovac, M., Molin, S., Prinz, J. C., Ruzicka, T., & Wollenberg, A. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09522.x · Cited by 59
Self-citationMethotrexate for treatment of atopic dermatitis in children and adolescents
Deo, M., Yung, A., Hill, S., & Rademaker, M. (2014) · International Journal of Dermatology · doi:10.1111/ijd.12314 · Cited by 57
Gerbens, L. A. A., Hamann, S. A. S., Brouwer, M. W. D., Roekevisch, E., Leeflang, M., & Spuls, P. I. (2017) · British Journal of Dermatology · doi:10.1111/bjd.16240 · Cited by 55
Self-citationMycophenolate mofetil and atopic dermatitis: systematic review and meta-analysis
Phan, K. H., & Smith, S. D. (2019) · Journal of Dermatological Treatment · doi:10.1080/09546634.2019.1642996 · Cited by 53
GRADE Leitlinien: 14. Von der Evidenz zur Empfehlung: Die Bedeutung und Darstellung von Empfehlungen
Kaminski-Hartenthaler, A., Meerpohl, J. J., Gartlehner, G., Kien, C., Langer, G., Wipplinger, J., & Schünemann, H. J. (2014) · Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen · doi:10.1016/j.zefq.2014.08.003 · Cited by 48
Drug survival of dupilumab compared to cyclosporin in moderate‐to‐severe atopic dermatitis patients
Bello, G. D., Maurelli, M., Schena, D., Girolomoni, G., & Gisondi, P. (2020) · Dermatologic Therapy · doi:10.1111/dth.13979 · Cited by 40
Self-citationThyssen, J. P., Vestergaard, C., Barbarot, S., de Bruin-Weller, M. S., Bieber, T. R. M., Taïeb, A., Sénéschal, J., Cork, M. J., Paul, C. F., Flohr, C., et al. (2021) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.17167 · Cited by 38
Self-citationRelative efficacy of systemic treatments for atopic dermatitis
Seger, E. W., Wechter, T., Strowd, L. C., & Feldman, S. R. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.09.053 · Cited by 36
Inborn Error of Immunity or Atopic Dermatitis: When to be Concerned and How to Investigate
Stadler, P., Renner, E. D., Milner, J. D., & Wollenberg, A. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.01.037 · Cited by 30
Self-citationSilverberg, J. I., Simpson, E. L., Armstrong, A. W., de Bruin-Weller, M. S., Irvine, A. D., & Reich, K. (2021) · American Journal of Clinical Dermatology · doi:10.1007/s40257-021-00639-y · Cited by 26
van der Schaft, J., van Zuilen, A. D., Deinum, J., Bruijnzeel-Koomen, C. A. F. M., & de Bruin-Weller, M. S. (2015) · Acta Dermato Venereologica · doi:10.2340/00015555-2125 · Cited by 23
Thomsen, S. F., Karlsmark, T., Clemmensen, K. K. B., Graversgaard, C., Ibler, K. S., Jemec, G. B. E., & Agner, T. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13495 · Cited by 21
Luchsinger, I., Vogler, T., Schwieger‐Briel, A., Knöpfel, N., Waelchli, R., Weibel, L., & Theiler, M. (2019) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16088 · Cited by 12
Cited by
Langley, R. G., Gherardi, G., Coleman, A., Ardeleanu, M., Rodríguez-Marco, A., Levy, S., Bansal, A., Chen, Z., Rossi, A. B., Shumel, B., et al. (2025) · American Journal of Clinical Dermatology · doi:10.1007/s40257-025-00952-w · Cited by 18
Metadata
- Authors
- Wollenberg, A., Kinberger, M., Arents, B., Aszodi, N., Avila Valle, G., Barbarot, S., Bieber, T., Brough, H. A., Calzavara Pinton, P., Christen‐Zäch, S., Deleuran, M., Dittmann, M., Dressler, C., Fink‐Wagner, A. H., Fosse, N., Gáspár, K., Gerbens, L., Gieler, U., Girolomoni, G., Gregoriou, S., Mortz, C. G., Nast, A., Nygaard, U., Redding, M., Rehbinder, E. M., Ring, J., Rossi, M., Serra‐Baldrich, E., Simon, D., Szalai, Z. Z., Szepietowski, J. C., Torrelo, A., Werfel, T., & Flohr, C.
- Venue
- Journal of the European Academy of Dermatology and Venereology
- Publisher
- Wiley
- Published
- 2022-08-18
- Volume
- 36
- Issue
- 9
- Pages
- 1409-1431
- ISSN
- 0926-9959 (ISSN-L)
- 1468-3083
- OpenAlex
- W4292684063
- Cited by
- 426
- References
- 81
- FWCI
- 71.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.